New CBO Study Compares Net Prices for Brand-Name Drugs Among Federal Programs, Finds Medicaid Gets Largest Discounts
In a new groundbreaking study, the Congressional Budget Office compared brand-name drug prices, net of rebates and discounts, across select federal programs and agencies including Medicaid, Medicare Part D and the Department of Veterans Affairs (VA). It found that Medicaid gets the lowest net prices, far below that of Medicare Part D plans and well […]